Skip to main content
Log in

Differential thrombogenicity of artery and vein: The role of von Willebrand factor

  • Papers from the Peripheral Vascular Surgery Society
  • Published:
Annals of Vascular Surgery

Abstract

There exists clinical evidence for a difference in the relative thrombogenicity of arterial and venous surfaces. We studied this phenomenon in an in vitro model where the effects of hemodynamic differences could be controlled. Nonanticoagulated human blood was perfused across injured (air-insufflated) arterial and venous surfaces in a recirculating perfusion system at shear rates of 500 and 1500/sec. Thrombus formation was assessed by measuring radiolabeled platelet (111 In) and fibrin (125I)deposition on the surfaces. The role of von Willebrand factor (vWF) in arterial and venous thrombosis was evaluated by blocking its effect with polyclonal anti-vWF antibody (vWF Ab). Raw data were converted to log 10 for statistical analysis. The increased thrombogenicity of injured venous vs. arterial segments was confirmed by these studies (p<0.001).The addition of vWF Ab decreased platelet and fibrin deposition (p<0.001)and these effects were greater in veins than in arteries. The difference in platelet deposition between arteries and veins was more pronounced at lower shear rates (p<0.05),an effect not observed with fibrin deposition. To determine whether the increased thrombogenicity of veins could be explained by an increased content of subendothelial vWF, the amount of vWF was assessed by incubating injured vessels with 125 I vWF Ab and then measuring the radioactivity of the vessels. Veins had a higher content of vWF than arteries, as implied by the higher amount of radiolabeled vWF Ab (813±90 in veins vs. 2173±317 in arteries,p<0.001).These observations suggest that increased thrombogenicity of veins may in part be explained by intrinsic differences in subendothelial vWF and subsequent platelet attachment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bahnak BR, Wu QY, Coulombel L, et al. Expression of von Willebrand factor in porcine vessels. Heterogeneity at the level of von Willebrand factor mRNA. J Cell Physiol 1989; 138:305–310.

    PubMed  Google Scholar 

  2. Badimon L, Badimon JJ, Rand JH, et al. Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood. J Lab Clin Med 1987; 110:634–647.

    PubMed  Google Scholar 

  3. Hantgan RR, Hindriks G, Taylor RG, et al. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb ∶ IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 1990;76:345–353.

    PubMed  Google Scholar 

  4. Lawrence JB, Gralnick HR. Monoclonal antibodies to the glycoprotein IIb/IIIa epitopes involved in adhesive protein binding: Effects on platelet spreading and ultrastructure on human arterial subendothelium. J Lab Clin Med 1987;109: 495–503.

    PubMed  Google Scholar 

  5. Morris CJ. Preoperative prediction of post-operative deep vein thrombosis. Thromb Haemost 1979;41:27–32.

    PubMed  Google Scholar 

  6. Prevention of venous thrombosis and pulmonary embolism. National Institutes of Health Consensus Development Conference Consensus Statement. 1986;6:1–8.

    Google Scholar 

  7. Sack GH Jr, Levin J, Bell W. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical pathophysiologic, and therapeutic features. Medicine 1977;56:1–37.

    PubMed  Google Scholar 

  8. Caprini JA, Sener SF. Altered coagulability in cancer patients. Cancer 1982;32:162–172.

    Google Scholar 

  9. Boyce B. Physical characteristics of expanded polytetrafluoroethylene grafts. In Stanley JC, Burkel WE, Lindenauer SM, et al., eds. Biologic and Synthetic Vascular Prostheses. New York: Grune & Stratton, 1982, pp 553–561.

    Google Scholar 

  10. Loscalzo J, Inbal A, Handin RI. von Willebrand protein facilitates platelet incorporation in polymerizing fibrin. J Clin Invest 1986;78:1112–1119.

    PubMed  Google Scholar 

  11. Moake JL, Turner NA, Stathopoulos NA, et al. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988;71:1366–1374.

    PubMed  Google Scholar 

  12. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol 1990;6:217–246.

    PubMed  Google Scholar 

  13. Sporn LA, Marder VJ, Wagner DD. von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood 1987;69:1531–1534.

    PubMed  Google Scholar 

  14. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986;46:185–190.

    PubMed  Google Scholar 

  15. Vauthey JN, Lerut J. An “open-closed” technique for the treatment of necrotizing pancreatitis. Am J Surg 1993; 165: 277–281.

    PubMed  Google Scholar 

  16. Moake JL, Turner NA, Stathopoulos NA, et al. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 78:1456–1461.

    PubMed  Google Scholar 

  17. Hong SL, Weinstein MJ, Moake JL. von Willebrand factor multimer forms produced by human endothelial cells [abst]. Blood 1983;62(Suppl 1):286a.

    Google Scholar 

  18. Rand JH, Badimon L, Gordon RE, et al. Distribution of von Willebrand factor in porcine intima varies with blood vessel type and location. Arteriosclerosis 1987;7:287–291.

    PubMed  Google Scholar 

  19. Giddings JC, Jarvis AL, Bloom AL. Differential localisation and synthesis of porcine factor VIII related antigen (VIII: Ag) in vascular endothelium and in endothelial cells in culture. Thromb Res 1983;29:299–312.

    PubMed  Google Scholar 

  20. Badimon L, Badimon JJ, Turitto VT, et al. Platelet thrombus formation on collagen type I: A model of deep vessel injury: Influence of blood rheology, von Willebrand factor, and blood coagulation. Circulation 1988;78:1431–1442.

    PubMed  Google Scholar 

  21. Badimon L, Badimon JJ, Turitto VT, et al. Role of von Willebrand factor in mediating platelet-vessel wall interaction at low shear rate: The importance of perfusion conditions. Blood 1989;73:961–967.

    PubMed  Google Scholar 

  22. Weiss HJ, Turitto VT, Baumgartner HR, et al. Evidence for the presence of tissue factor activity on subendothelium. Blood 1989, 73:968–975.

    PubMed  Google Scholar 

  23. Jang I-K, Gold HK, Leinbach RC, et al. Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis. Arterioscler Thromb 1992; 12:948–954.

    PubMed  Google Scholar 

  24. Astrup T, Buluk K. Thromboplastic and fibrinolytic activities in vessels of animals. Circ Res 1963;13:253–260.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grant HL 40889 from the National Institutes of Health, Bethesda, Md.

About this article

Cite this article

Cho, J.S., Ouriel, K. Differential thrombogenicity of artery and vein: The role of von Willebrand factor. Annals of Vascular Surgery 9, 60–70 (1995). https://doi.org/10.1007/BF02015318

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02015318

Keywords

Navigation